Vivo Capital is a global healthcare investment firm based in Palo Alto, CA, with over 25 years of experience and approximately $5.4 billion in assets under management. They focus on investing in promising private and public healthcare companies, providing growth capital, private equity, and venture capital funding. Their investments span the healthcare industry, including pharmaceuticals, biotechnology, and medical devices, with a primary focus on the U.S. and Greater China.
Vivo Capital operates through three fund vehicles: Vivo Capital Fund IX, Vivo Opportunity Fund, and Vivo Innovation Fund (PANDA Fund). These funds invest in different stages of companies, from early-stage venture financing to growth capital and private equity investments. With a team of experienced partners and a track record of successful investments, Vivo Capital aims to drive value creation and support the development of game-changing healthcare technologies and products.
Generated from the website